Resource use and survival of patients hospitalized with congestive heart failure: Differences in care by specialty of the attending physician

Annals of Internal Medicine

Volumn 132, Issue 3, 2000, Pages 191-200

  Auerbach, Andrew D ^a   Hamel, Mary Beth ^b   Davis, Roger B ^b   Connors Jr , Alfred F ^c   Regueiro, Carol ^d   Desbiens, Norman ^e   Goldman, Lee ^a   Califf, Robert M ^f   Dawson, Neal V ^g   Wenger, Neil ^h   Vidaillet, Humberto ⁱ   Phillips, Russell S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d ALLEGHENY GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g METROHEALTH MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESOURCE MANAGEMENT; SURVIVAL;

EID: 0034141827     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-3-200002010-00004     Document Type: Article

References (45)

1. Cohen JJ. Transforming the size and composition of the physician work force to meet !he demands of health care reform. N Engl J Med. 1993;329:1810-2.
2. Greenfield S, Nelson EC, Zubkoff M, Manning W, Rogers W, Kravitz RL, et al. Variations in resource utilization among medical subspecialties and systems of care Results from the Medical Outcomes Study. JAMA. 1992;267: 1624-30.
3. Ward MM, Leigh JP, Fries JF. Progression of functional disability in patients with rheumatoid arthritis Associations with rheumatology subspecialty care. Arch Intern Med. 1993;153:2229-37.
4. Pollack MM, Katz RW, Ruttimann UE, Getson PR. Improving the outcome and efficiency of intensive care: the impact of an intensivist. Crit Care Med. 1988;16:11-7.
5. Goldman L. The value of cardiology [Editorial]. N Engl J Med 1996;335: 1918-9.
6. Jollis JG, DeLong ER. Peterson ED, Muhlbaier LH, Fortin DF, Califf RM, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996;335:1880-7.
7. Casale PN, Jones JL, Wolf FE, Pei Y, Eby LM. Patents treated by cardiologists have a lower in-hospital mortality for acute myocardial infarction. J Am Coll Cardiol. 1998:32:885-9.
8. Ayanian JZ, Guadagnoli E, McNeil BJ, Cleary PD. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians. Arch Intern Med. 1997;157:2570-6.
9. Schreiber TL, Elkhatib A, Grines CL, O'Neill WW. Cardiologist versus internist management of patients with unstable angina' treatment oatterns and outcomes. J Am Coll Cardiol. 1995;26:577-82.
10. Selby JV, Fireman BH, Lundstrom RJ, Swain BE, Truman AF, Wong CC, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med. 1995;335:1888-96.
11. Harjai KJ, Boulos LM, Smart FW, Turgut T, Krousel-Wood MA, Stapleton DD, et al. Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure. Am J Carciol. 1998;82:82-5.
12. Reis SE, Holubkov R, Edmundowicz D, McNamara DM, Zell KA, Detre KM, et al. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol. 1997;30:733-8.
13. A controlled trial to improve care for seriously ill hospitalized patients. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA. 1995; 274:1591-8.
14. Lynn J, Knaus WA. Background for SUPPORT J Clin Epidemiol. 1990;43:1S-4S.
15. Kreling B, Robinson DK, Bergner M. Data collection strategies in SUPPORT. J Clin Epidemiol. 1990;43:5S-9S.
16. Murphy DJ, Knaus WA, Lynn J. Study population in SUPPORT: patients (as defined by disease categories and mortality projections), surrogates, and physicians. J Clin Epidemiol. 1990;43:11S-28S.
17. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-36.
18. Knaus WA, Harrell FE, Lynn J, Goldman L, Phillips RS, Connors AF Jr, et al. The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med. 1995;122:191-203.
19. Keene AR, Cullen DJ. Therapeutic Intervention Scoring System: update 1983. Crit Care Med. 1983;11:1-3.
20. Rosenbaum PR, Dubin DB. Reducing bias in observational studies using subclassification on the propensity score. Journal of the American Statistical Association. 1984;79:516-24.
21. Rosenbaum PR, Dubin DB. The central role of the propensity score in observational studies for causal effects Biometrika. 1983;70:41-55.
22. Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observationa studies. Biometrics 1998; 54:948-63.
23. Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and non-insulin-dependent diabetes mellitus treated by different systems and specialties. Results from the Medical Outcomes Study. JAMA. 1995;274:1436-44.
24. Strauss MJ, Conrad D, LoGerfo JP, Hudson LD, Bergner M. Costs and outcomes for patients with chronic obstructive lung disease. Analysis by physician specialty. Med Care. 1986;24:915-24.
25. Regueiro CR, Hamel MB, Davis RB, Desbiens N, Connors AF Jr, Phillips RS. A comparison of specialist and generalist care of patients hospitalized with severe chronic obstructive pulmonary disease. SUPPORT Investigators Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Am J Med. 1998;105:366-72.
26. Willison DJ, Soumerai SB, McLaughlin TJ, Gurwitz JH, Gao X, Guadagnoli E, et al. Consultation between cardiologists and generalists in the management of acute myocardial infarction: implications for quality of care. Arch Intern Med. 1998;158:1778-83.
27. Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, et al. Nonsustamed ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation. 1996;94:3198-203.
28. Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G. Mechanism of death in heart failure. The Vasodilator-Heart Failure trials. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87(6 Suppl):VI24-31.
29. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995;333:77-82.
30. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiensia Cardiaca en Argentina. Lancet 1994;344:493-8.
31. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992;123: 421-6.
32. Van den Berg MP, Tuinenberg AE, Crijns HJ, Van Gelder I, Gosselink AT, Lie KI. Heart failure and atrial fibrillation: current concepts and controversies. Heart. 1997;77:309-13.
33. Dalen JE, Bone RC. Is it time to pull the pulmonary artery catheter? [Editorial] JAMA. 1996;276:916-8.
34. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA. 1996;276:889-97.
35. Lee TH, Goldman L The coronary care unit turns 25: historical trends and future directions. Ann Intern Med. 1988;108:887-94.
36. Karlson BW, Herlitz J, Wiklund O, Pettersson P, Hallgren P, Hjalmarson A. Characteristics and prognosis of patients with acute myocardial infarction in relation to whether they were treated in the coronary care unit or in another ward. Cardiology. 1992;81:134-44.
37. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994;272:1528-34.
38. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazme-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-10.
39. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429-35.
40. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med. 1992;327:685-91.
41. Leier CV, Dei Cas L, Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponalremia, hypokalemia, and hypomagnesemia. Am Heart J. 1994;126:564-74.
42. Hughes CV, Wong M, Johnson G, Cohn JN. Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies Group Circulation. 1993;87(6 Suppl):VI1117.
43. Edwards BS, Rodeheffer RJ. Prognostic features in patients with congestive heart failure and selection criteria for cardiac transplantation. Mayo Clin Proc. 1992;67:485-92.
44. Rickenbacher PR, Trindade PT, Haywood GA, Vagelos RH, Schroeder JS, Willson K, et al. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. J Am Coll Cardiol. 1996;27:1192-7.
45. van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with nild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;70:359-63.